Molecular Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032

Description

Persistence Market Research has recently released a comprehensive report on the worldwide market for molecular diagnostics. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global molecular diagnostics market from 2025 to 2032.

Key Insights:

Molecular Diagnostics Market Size (2025E): USD 5.9 Billion
Projected Market Value (2032F): USD 9.1 Billion
Global Market Growth Rate (CAGR 2025 to 2032): 6.4%

Molecular Diagnostics Market - Report Scope:

Molecular diagnostics refers to advanced testing techniques used to analyze biological markers in the genome and proteome for the detection of diseases, monitoring of treatment response, and identification of genetic variations. These diagnostics include technologies such as polymerase chain reaction (PCR), next-generation sequencing (NGS), in situ hybridization, microarrays, and isothermal nucleic acid amplification. The market serves applications across infectious diseases, oncology, genetic screening, cardiovascular disorders, and personalized medicine. Rising demand for accurate, rapid, and early-stage disease detection continues to strengthen market adoption globally.

Market Growth Drivers:

The global molecular diagnostics market is primarily driven by the increasing prevalence of infectious and chronic diseases, creating strong demand for precise and rapid diagnostic solutions. Growing adoption of personalized medicine and companion diagnostics is accelerating the use of molecular testing in oncology and rare disease management. Technological advancements in PCR automation, multiplex assays, and sequencing platforms are improving testing efficiency and accessibility. In addition, rising awareness regarding preventive healthcare, expanding screening programs, and greater use of point-of-care molecular diagnostics are contributing significantly to market growth.

Market Restraints:

Despite favorable growth prospects, the market faces challenges such as high costs associated with molecular testing instruments and reagents. Complex regulatory approval processes and strict quality compliance requirements may delay commercialization of innovative products. Limited reimbursement coverage in certain healthcare systems and shortage of skilled laboratory professionals can also restrict market expansion. Furthermore, infrastructure limitations in low- and middle-income countries may hinder widespread adoption.

Market Opportunities:

The molecular diagnostics market presents substantial opportunities through the rapid expansion of decentralized and point-of-care testing solutions. Increasing integration of artificial intelligence, cloud-based analytics, and automation in laboratories is expected to enhance workflow efficiency and result accuracy. Growing use of liquid biopsy, non-invasive prenatal testing, and pharmacogenomics is opening new revenue streams. Emerging healthcare markets in Asia Pacific, Latin America, and the Middle East are also likely to create strong demand due to improving healthcare infrastructure and rising disease awareness.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the molecular diagnostics market globally?
Which technologies and applications are leading revenue generation in the molecular diagnostics ecosystem?
How are automation, AI, and precision medicine transforming molecular diagnostics platforms?
Who are the key players in the molecular diagnostics market, and what strategies are they using to stay competitive?
What are the emerging trends and future growth prospects in the global molecular diagnostics market?

Competitive Intelligence and Business Strategy:

Leading companies in the molecular diagnostics market are focusing on expanding assay portfolios, strengthening automation capabilities, and investing in next-generation sequencing technologies. Strategic collaborations with hospitals, laboratories, and biotechnology firms are accelerating product innovation and market penetration. Companies are also pursuing mergers and acquisitions to enhance regional presence and broaden technological expertise. In addition, major players are emphasizing cost-efficient testing platforms, rapid turnaround solutions, and digital integration to maintain competitive advantage. ([Reuters][2])

Key Companies Profiled:

F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Thermo Fisher Scientific Inc.
Danaher Corporation
bioMerieux SA
QIAGEN N.V.
Siemens Healthineers AG
Hologic Inc.
Illumina Inc.
Becton, Dickinson and Company

Molecular Diagnostics Market Research Segmentation:

By Product:

Instruments
Reagents & Consumables
Software & Services

By Technology:

PCR
Next-Generation Sequencing (NGS)
In Situ Hybridization
Microarrays
Isothermal Nucleic Acid Amplification
Others

By Application:

Infectious Diseases
Oncology
Genetic Testing
Blood Screening
Cardiovascular Diseases
Others

By End User:

Hospitals
Diagnostic Laboratories
Academic & Research Institutes
Point-of-Care Settings
Others

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Product Code: PMRREP2784

1. Executive Summary

1.1. Global Molecular Diagnostics Market Snapshot 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Industry Developments and Key Market Events
1.5. Demand Side and Supply Side Analysis
1.6. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definitions
2.2. Value Chain Analysis
2.3. Macro-Economic Factors
- 2.3.1. Global GDP Outlook
- 2.3.2. Global GDP Outlook
- 2.3.3. Global economic Growth Forecast
- 2.3.4. Global Urbanization Growth
- 2.3.5. Other Macro-economic Factors
2.4. Forecast Factors - Relevance and Impact
2.5. COVID-19 Impact Assessment
2.6. PESTLE Analysis
2.7. Porter's Five Forces Analysis
2.8. Geopolitical Tensions: Market Impact
2.9. Regulatory and Technology Landscape

3. Market Dynamics

3.1. Drivers
3.2. Restraints
3.3. Opportunities
3.4. Trends

4. Price Trend Analysis, 2019 - 2032

4.1. Region-wise Price Analysis
4.2. Price by Segments
4.3. Price Impact Factors

5. Global Molecular Diagnostics Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)

5.1. Key Highlights
5.2. Global Molecular Diagnostics Market Outlook: Product Type
- 5.2.1. Introduction/Key Findings
- 5.2.2. Historical Market Size (US$ Bn) Analysis by Product Type, 2019-2024
- 5.2.3. Current Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
  - 5.2.3.1. Instruments
    - 5.2.3.1.1. Polymerase Chain Reaction (PCR) Systems
    - 5.2.3.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
    - 5.2.3.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
    - 5.2.3.1.4. Microarrays
  - 5.2.3.2. Reagent
    - 5.2.3.2.1. Antibodies
    - 5.2.3.2.2. DNA Template
    - 5.2.3.2.3. DNA Polymerase
    - 5.2.3.2.4. Oligonucleotide Primers
    - 5.2.3.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
    - 5.2.3.2.6. Buffer
  - 5.2.3.3. Assay Kits
  - 5.2.3.4. Consumables
- 5.2.4. Market Attractiveness Analysis: Product Type
5.3. Global Molecular Diagnostics Market Outlook: Disease Area
- 5.3.1. Introduction/Key Findings
- 5.3.2. Historical Market Size (US$ Bn) Analysis by Disease Area, 2019-2024
- 5.3.3. Current Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
  - 5.3.3.1. Infectious Disease
  - 5.3.3.2. Diabetes
  - 5.3.3.3. Cardiology
  - 5.3.3.4. Oncology
  - 5.3.3.5. Nephrology
  - 5.3.3.6. Autoimmune Disease
  - 5.3.3.7. Dermatology
  - 5.3.3.8. Wound Care
  - 5.3.3.9. Others
- 5.3.4. Market Attractiveness Analysis: Disease Area
5.4. Global Molecular Diagnostics Market Outlook: End-use
- 5.4.1. Introduction/Key Findings
- 5.4.2. Historical Market Size (US$ Bn) Analysis by End-use, 2019-2024
- 5.4.3. Current Market Size (US$ Bn) Forecast, by End-use, 2025-2032
  - 5.4.3.1. Hospitals & Clinics
  - 5.4.3.2. Diagnostics Laboratories
  - 5.4.3.3. Academic and Research Institutes
  - 5.4.3.4. Biopharmaceutical Companies
- 5.4.4. Market Attractiveness Analysis: End-use

6. Global Molecular Diagnostics Market Outlook: Region

6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis by Region, 2019-2024
6.3. Current Market Size (US$ Bn) Forecast, by Region, 2025-2032
- 6.3.1. North America
- 6.3.2. Europe
- 6.3.3. East Asia
- 6.3.4. South Asia & Oceania
- 6.3.5. Latin America
- 6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region

7. North America Molecular Diagnostics Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. North America Market Size (US$ Bn) Forecast, by Country, 2025-2032
- 7.3.1. U.S.
- 7.3.2. Canada
7.4. North America Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
- 7.4.1. Instruments
  - 7.4.1.1. Polymerase Chain Reaction (PCR) Systems
  - 7.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
  - 7.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
  - 7.4.1.4. Microarrays
- 7.4.2. Reagent
  - 7.4.2.1. Antibodies
  - 7.4.2.2. DNA Template
  - 7.4.2.3. DNA Polymerase
  - 7.4.2.4. Oligonucleotide Primers
  - 7.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
  - 7.4.2.6. Buffer
- 7.4.3. Assay Kits
- 7.4.4. Consumables
7.5. North America Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
- 7.5.1. Infectious Disease
- 7.5.2. Diabetes
- 7.5.3. Cardiology
- 7.5.4. Oncology
- 7.5.5. Nephrology
- 7.5.6. Autoimmune Disease
- 7.5.7. Dermatology
- 7.5.8. Wound Care
- 7.5.9. Others
7.6. North America Market Size (US$ Bn) Forecast, by End-use, 2025-2032
- 7.6.1. Hospitals & Clinics
- 7.6.2. Diagnostics Laboratories
- 7.6.3. Academic and Research Institutes
- 7.6.4. Biopharmaceutical Companies

8. Europe Molecular Diagnostics Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Europe Market Size (US$ Bn) Forecast, by Country, 2025-2032
- 8.3.1. Germany
- 8.3.2. Italy
- 8.3.3. France
- 8.3.4. U.K.
- 8.3.5. Spain
- 8.3.6. Russia
- 8.3.7. Rest of Europe
8.4. Europe Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
- 8.4.1. Instruments
  - 8.4.1.1. Polymerase Chain Reaction (PCR) Systems
  - 8.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
  - 8.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
  - 8.4.1.4. Microarrays
- 8.4.2. Reagent
  - 8.4.2.1. Antibodies
  - 8.4.2.2. DNA Template
  - 8.4.2.3. DNA Polymerase
  - 8.4.2.4. Oligonucleotide Primers
  - 8.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
  - 8.4.2.6. Buffer
- 8.4.3. Assay Kits
- 8.4.4. Consumables
8.5. Europe Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
- 8.5.1. Infectious Disease
- 8.5.2. Diabetes
- 8.5.3. Cardiology
- 8.5.4. Oncology
- 8.5.5. Nephrology
- 8.5.6. Autoimmune Disease
- 8.5.7. Dermatology
- 8.5.8. Wound Care
- 8.5.9. Others
8.6. Europe Market Size (US$ Bn) Forecast, by End-use, 2025-2032
- 8.6.1. Hospitals & Clinics
- 8.6.2. Diagnostics Laboratories
- 8.6.3. Academic and Research Institutes
- 8.6.4. Biopharmaceutical Companies

9. East Asia Molecular Diagnostics Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. East Asia Market Size (US$ Bn) Forecast, by Country, 2025-2032
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. South Korea
9.4. East Asia Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
- 9.4.1. Instruments
  - 9.4.1.1. Polymerase Chain Reaction (PCR) Systems
  - 9.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
  - 9.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
  - 9.4.1.4. Microarrays
- 9.4.2. Reagent
  - 9.4.2.1. Antibodies
  - 9.4.2.2. DNA Template
  - 9.4.2.3. DNA Polymerase
  - 9.4.2.4. Oligonucleotide Primers
  - 9.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
  - 9.4.2.6. Buffer
- 9.4.3. Assay Kits
- 9.4.4. Consumables
9.5. East Asia Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
- 9.5.1. Infectious Disease
- 9.5.2. Diabetes
- 9.5.3. Cardiology
- 9.5.4. Oncology
- 9.5.5. Nephrology
- 9.5.6. Autoimmune Disease
- 9.5.7. Dermatology
- 9.5.8. Wound Care
- 9.5.9. Others
9.6. East Asia Market Size (US$ Bn) Forecast, by End-use, 2025-2032
- 9.6.1. Hospitals & Clinics
- 9.6.2. Diagnostics Laboratories
- 9.6.3. Academic and Research Institutes
- 9.6.4. Biopharmaceutical Companies

10. South Asia & Oceania Molecular Diagnostics Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. South Asia & Oceania Market Size (US$ Bn) Forecast, by Country, 2025-2032
- 10.3.1. India
- 10.3.2. Southeast Asia
- 10.3.3. ANZ
- 10.3.4. Rest of SAO
10.4. South Asia & Oceania Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
- 10.4.1. Instruments
  - 10.4.1.1. Polymerase Chain Reaction (PCR) Systems
  - 10.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
  - 10.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
  - 10.4.1.4. Microarrays
- 10.4.2. Reagent
  - 10.4.2.1. Antibodies
  - 10.4.2.2. DNA Template
  - 10.4.2.3. DNA Polymerase
  - 10.4.2.4. Oligonucleotide Primers
  - 10.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
  - 10.4.2.6. Buffer
- 10.4.3. Assay Kits
- 10.4.4. Consumables
10.5. South Asia & Oceania Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
- 10.5.1. Infectious Disease
- 10.5.2. Diabetes
- 10.5.3. Cardiology
- 10.5.4. Oncology
- 10.5.5. Nephrology
- 10.5.6. Autoimmune Disease
- 10.5.7. Dermatology
- 10.5.8. Wound Care
- 10.5.9. Others
10.6. South Asia & Oceania Market Size (US$ Bn) Forecast, by End-use, 2025-2032
- 10.6.1. Hospitals & Clinics
- 10.6.2. Diagnostics Laboratories
- 10.6.3. Academic and Research Institutes
- 10.6.4. Biopharmaceutical Companies

11. Latin America Molecular Diagnostics Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)

11.1. Key Highlights
11.2. Pricing Analysis
11.3. Latin America Market Size (US$ Bn) Forecast, by Country, 2025-2032
- 11.3.1. Brazil
- 11.3.2. Mexico
- 11.3.3. Rest of LATAM
11.4. Latin America Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
- 11.4.1. Instruments
  - 11.4.1.1. Polymerase Chain Reaction (PCR) Systems
  - 11.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
  - 11.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
  - 11.4.1.4. Microarrays
- 11.4.2. Reagent
  - 11.4.2.1. Antibodies
  - 11.4.2.2. DNA Template
  - 11.4.2.3. DNA Polymerase
  - 11.4.2.4. Oligonucleotide Primers
  - 11.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
  - 11.4.2.6. Buffer
- 11.4.3. Assay Kits
- 11.4.4. Consumables
11.5. Latin America Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
- 11.5.1. Infectious Disease
- 11.5.2. Diabetes
- 11.5.3. Cardiology
- 11.5.4. Oncology
- 11.5.5. Nephrology
- 11.5.6. Autoimmune Disease
- 11.5.7. Dermatology
- 11.5.8. Wound Care
- 11.5.9. Others
11.6. Latin America Market Size (US$ Bn) Forecast, by End-use, 2025-2032
- 11.6.1. Hospitals & Clinics
- 11.6.2. Diagnostics Laboratories
- 11.6.3. Academic and Research Institutes
- 11.6.4. Biopharmaceutical Companies

12. Middle East & Africa Molecular Diagnostics Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)

12.1. Key Highlights
12.2. Pricing Analysis
12.3. Middle East & Africa Market Size (US$ Bn) Forecast, by Country, 2025-2032
- 12.3.1. GCC Countries
- 12.3.2. South Africa
- 12.3.3. Northern Africa
- 12.3.4. Rest of MEA
12.4. Middle East & Africa Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
- 12.4.1. Instruments
  - 12.4.1.1. Polymerase Chain Reaction (PCR) Systems
  - 12.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
  - 12.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
  - 12.4.1.4. Microarrays
- 12.4.2. Reagent
  - 12.4.2.1. Antibodies
  - 12.4.2.2. DNA Template
  - 12.4.2.3. DNA Polymerase
  - 12.4.2.4. Oligonucleotide Primers
  - 12.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
  - 12.4.2.6. Buffer
- 12.4.3. Assay Kits
- 12.4.4. Consumables
12.5. Middle East & Africa Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
- 12.5.1. Infectious Disease
- 12.5.2. Diabetes
- 12.5.3. Cardiology
- 12.5.4. Oncology
- 12.5.5. Nephrology
- 12.5.6. Autoimmune Disease
- 12.5.7. Dermatology
- 12.5.8. Wound Care
- 12.5.9. Others
12.6. Middle East & Africa Market Size (US$ Bn) Forecast, by End-use, 2025-2032
- 12.6.1. Hospitals & Clinics
- 12.6.2. Diagnostics Laboratories
- 12.6.3. Academic and Research Institutes
- 12.6.4. Biopharmaceutical Companies

13. Competition Landscape

13.1. Market Share Analysis, 2024
13.2. Market Structure
- 13.2.1. Competition Intensity Mapping
- 13.2.2. Competition Dashboard
13.3. Company Profiles
- 13.3.1. Becton, Dickinson and Company
  - 13.3.1.1. Company Overview
  - 13.3.1.2. Product Portfolio/Offerings
  - 13.3.1.3. Key Financials
  - 13.3.1.4. SWOT Analysis
  - 13.3.1.5. Company Strategy and Key Developments
- 13.3.2. Bio-Rad Laboratories In
- 13.3.3. Merck KgaA
- 13.3.4. Thermo Fisher Scientific Inc
- 13.3.5. Agilent Technologies, Inc.
- 13.3.6. F. Hoffman - La Roche Ltd.
- 13.3.7. Illumina, Inc.
- 13.3.8. Qiagen N.V.
- 13.3.9. Hologic Inc.
- 13.3.10. Siemens Healthineers AG
- 13.3.11. Seegene, Inc.
- 13.3.12. DiaSorin S.p.A
- 13.3.13. Grifols, S.A.
- 13.3.14. bioMerieux
- 13.3.15. QuidelOrtho Corporation

14. Appendix

14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations